AbbVie Inc.
BISPECIFIC BINDING MOLECULES
Last updated:
Abstract:
The present disclosure provides novel bispecific molecules that binds to human Survivin and human CD3, and methods of making and using the same.
Status:
Application
Type:
Utility
Filling date:
12 Feb 2021
Issue date:
19 Aug 2021